Qianjiang Yongan Pharmaceutical Co Ltd Strategic Asset Allocation Index
Qianjiang Yongan Pharmaceutical Co Ltd strategic asset allocation index. Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a Strategic Asset Allocation Index of 46.9% as of September 2023. Strategic assets (PP&E of CN¥994.22 Million plus long-term investments of CN¥-) total CN¥994.22 Million, measured against net assets of CN¥2.12 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 002365 net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Qianjiang Yongan Pharmaceutical Co Ltd (2009–2021)
Strategic asset allocation index of Qianjiang Yongan Pharmaceutical Co Ltd from 2009 to 2021. This chart shows how Qianjiang Yongan Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 13 annual periods from 2009 to 2021. As of September 2023, the index stands at 46.9%, representing strategic assets of CN¥994.22 Million against net assets of CN¥2.12 Billion CNY. Check 002365 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Qianjiang Yongan Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2009–2021)
Qianjiang Yongan Pharmaceutical Co Ltd strategic asset allocation index by year from 2009 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Qianjiang Yongan Pharmaceutical Co Ltd from 2009 to 2021, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002365 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 50.5% | CN¥988.96 Million | CN¥988.96 Million | CN¥- | CN¥1.96 Billion | ▼ -4.0 pp |
| 2020 | 54.6% | CN¥989.60 Million | CN¥989.60 Million | CN¥- | CN¥1.81 Billion | ▼ -6.4 pp |
| 2019 | 61.0% | CN¥1.01 Billion | CN¥1.01 Billion | CN¥- | CN¥1.66 Billion | ▼ -2.3 pp |
| 2018 | 63.2% | CN¥1.02 Billion | CN¥1.02 Billion | CN¥- | CN¥1.61 Billion | ▲ +13.8 pp |
| 2017 | 49.4% | CN¥664.53 Million | CN¥664.53 Million | CN¥- | CN¥1.34 Billion | ▲ +2.2 pp |
| 2016 | 47.2% | CN¥556.01 Million | CN¥556.01 Million | CN¥- | CN¥1.18 Billion | ▼ -6.0 pp |
| 2015 | 53.3% | CN¥596.22 Million | CN¥596.22 Million | CN¥- | CN¥1.12 Billion | ▼ -4.0 pp |
| 2014 | 57.2% | CN¥634.11 Million | CN¥634.11 Million | CN¥- | CN¥1.11 Billion | ▼ -6.8 pp |
| 2013 | 64.1% | CN¥691.74 Million | CN¥691.74 Million | CN¥- | CN¥1.08 Billion | ▲ +5.7 pp |
| 2012 | 58.4% | CN¥638.63 Million | CN¥638.63 Million | CN¥- | CN¥1.09 Billion | ▲ +14.0 pp |
| 2011 | 44.4% | CN¥468.67 Million | CN¥468.67 Million | CN¥- | CN¥1.06 Billion | ▲ +18.8 pp |
| 2010 | 25.6% | CN¥259.49 Million | CN¥259.49 Million | CN¥- | CN¥1.01 Billion | ▼ -42.9 pp |
| 2009 | 68.4% | CN¥221.84 Million | CN¥221.84 Million | CN¥- | CN¥324.17 Million | — |